StonvexLoading…
StonvexStonvexStonvexCore line items from CERS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $233.80M | $201.32M | $186.80M | $188.31M |
Operating Income | $-8.68M | $-14.22M | $-30.05M | $-34.08M |
Net Income | $-15.63M | $-20.92M | $-37.49M | $-42.78M |
EPS (Diluted) | $-0.08 | $-0.11 | $-0.21 | $-0.24 |
Total Assets | $221.86M | $200.92M | $197.75M | $218.09M |
Total Liabilities | $156.89M | $144.02M | $144.30M | $149.53M |
Cash & Equivalents | $19.96M | $20.27M | $11.65M | $35.59M |
Free Cash Flow OCF − CapEx | $1.11M | $8.52M | $-47.77M | $-27.61M |
Shares Outstanding | 192.14M | 185.77M | 181.25M | 177.58M |